Dr. David Louis Schwartz, MD

Dr. Schwartz practices at Memphis Radiological in Germantown, Tennessee.

Dr. Schwartz's NPI, 1922104157, was assigned on September 15, 2006. Dr. Schwartz graduated from David Geffen School of Medicine at UCLA in 1994. Dr. Schwartz's Tennessee license number on file is 54668.

Dr. Schwartz's primary practice is Memphis Radiological, at 7695 Poplar Pike, Germantown, TN 38138 in Shelby County. The practice phone is (901) 685-2696.

Dr. Schwartz's primary practice is Memphis Radiological in Germantown, Tennessee. Dr. Schwartz is also affiliated with Methodist University Hospital. The medical group on file is Baptist Medical Group. Dmand AI also links Dr. Schwartz to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schwartz practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Schwartz's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Schwartz is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Schwartz's licenses on file in 5 states: Tennessee, Mississippi, Texas, New York and Washington.

Dmand AI lists head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Schwartz treats.

CMS data shows 16 Medicare services from Dr. Schwartz across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $993 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Schwartz in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schwartz's median patient age at 69, with 32% women.

In 2024, Dr. Schwartz wrote 35 Medicare Part D claims for 19 patients. 89% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $136 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Schwartz for performance year 2024, reported as part of a group. Dr. Schwartz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 92 papers to Dr. Schwartz, published from 2007 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Radiotherapy Dosage. Dr. Schwartz has published most often in Int J Radiat Oncol Biol Phys. Dr. Schwartz's most frequent co-authors are David Schwartz, BS, BSN, FNP-BC, MS, William H. Morrison, MD and David I. Rosenthal, MD.

CMS Open Payments shows 20 general payments to Dr. Schwartz from 4 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 78% of the total. Elekta, Inc. paid the most, $5,808.

Dr. Schwartz graduated from David Geffen School of Medicine at UCLA in 1994.

Dr. Schwartz is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.